ISTH 2024

Octapharma Under the Spotlight Symposium

Learn About Tomorrow's Advances Today - Breakthrougs in All-Round Bleed Protection

Sunday, June 23, 2024
12:15 - 13:30 ICT
Room 208

Join us to learn about clinical and scientific advances in care for patients with haemophilia A. Results from the first interim analysis of the MOTIVATE study in ITI will be presented, alongside novel scientific data examining the role of FVIII in platelet binding, endothelial cell binding and joint and bone health.

Symposium programme



Welcome and Introduction

Chair: Guy Young, US

First Results From the MOTIVATE Study

Carmen Escuriola Ettingshausen, DE

FVIII Binding to Platelets: Are There Differences Between the Products?

Viola Vogel, CH

Generating Long-Term Data on Bone and Joint Health: The PROVE Study

Yesim Dargaud, FR

Exploring the Functionality of Endothelial Cells in Haemophilia A

Antonia Follenzi, IT


Speakers and Audience

This symposium is for healthcare professionals only and is organised and sponsored by Octapharma. This is a promotional symposium and Octapharma products will be discussed. Before prescribing any product, always refer to local materials such as the prescribing information and/or the summary of product characteristics.

Meet the speakers

Chair: Guy Young

Carmen Escuriola Ettingshausen

Viola Vogel

Yesim Dargaud

Antonia Follenzi

Join live on One Source

In case you cannot join us in person for the ISTH congress in Bangkok, we invite you to watch our symposium live on One Source, Octapharma's online platform.

The event is for healthcare professional only.